HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Katerina Akassoglou Selected Research

Rupture

4/2010Fibrinogen triggers astrocyte scar formation by promoting the availability of active TGF-beta after vascular damage.
7/2007Fibrinogen inhibits neurite outgrowth via beta 3 integrin-mediated phosphorylation of the EGF receptor.
6/2004Fibrin mechanisms and functions in nervous system pathology.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Katerina Akassoglou Research Topics

Disease

15Multiple Sclerosis
01/2023 - 04/2004
14Neuroinflammatory Diseases
04/2024 - 04/2004
12Alzheimer Disease (Alzheimer's Disease)
01/2023 - 06/2004
11Inflammation (Inflammations)
04/2024 - 04/2004
8Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
11/2023 - 03/2007
6Demyelinating Diseases (Demyelinating Disease)
11/2023 - 04/2004
6Cognitive Dysfunction
01/2022 - 12/2011
6Infections
11/2021 - 06/2008
5Stroke (Strokes)
01/2015 - 06/2004
3Gliosis
11/2023 - 04/2010
3Thrombosis (Thrombus)
10/2021 - 01/2012
3Cicatrix (Scar)
01/2020 - 04/2010
3Paralysis (Palsy)
01/2017 - 03/2007
3Hypoxia (Hypoxemia)
03/2012 - 06/2008
3Rupture
04/2010 - 06/2004
2Traumatic Brain Injuries (Traumatic Brain Injury)
04/2024 - 01/2012
2Wounds and Injuries (Trauma)
01/2023 - 01/2018
2Neoplasms (Cancer)
01/2021 - 01/2012
2Brain Injuries (Brain Injury)
01/2020 - 12/2012
2Neurodegenerative Diseases (Neurodegenerative Disease)
11/2018 - 06/2004
2Autoimmune Diseases (Autoimmune Disease)
10/2017 - 03/2007
2Insulin Resistance
01/2016 - 04/2012
2Fibrosis (Cirrhosis)
01/2012 - 06/2007
2Bacterial Infections (Bacterial Infection)
01/2012 - 06/2008
1Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked)
11/2023
1Systemic Scleroderma (Systemic Sclerosis)
01/2023
1Diffuse Scleroderma (Progressive Systemic Sclerosis)
01/2023
1COVID-19
10/2021
1Thromboinflammation
10/2021
1Tauopathies
01/2021
1Lymphoma (Lymphomas)
01/2021
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2021
1Amyloid Plaque
01/2019
1Relapsing-Remitting Multiple Sclerosis
01/2019
1Frontotemporal Dementia (Semantic Dementia)
01/2017
1Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
01/2017
1Weight Gain
01/2016
1Obesity
01/2016
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2016
1Hyperglycemia
01/2016
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2016
1Diabetic Retinopathy (Retinopathy, Diabetic)
01/2016
1Encephalomyelitis (Myeloencephalitis)
09/2015
1Endotoxemia
03/2015
1Sepsis (Septicemia)
08/2014

Drug/Important Bio-Agent (IBA)

21Fibrinogen (Factor I)FDA Link
04/2024 - 03/2007
12FibrinIBA
04/2024 - 01/2002
8Proteins (Proteins, Gene)FDA Link
10/2021 - 06/2004
7Blood Proteins (Serum Proteins)IBA
04/2024 - 04/2004
5Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA
01/2016 - 06/2007
3EpitopesIBA
10/2021 - 03/2007
3Blood Coagulation Factors (Coagulation Factor)IBA
10/2021 - 01/2021
3PlasminogenIBA
01/2017 - 06/2007
2Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2015
2ThrombinFDA Link
11/2021 - 02/2014
2Monoclonal AntibodiesIBA
10/2021 - 11/2018
2Therapeutic UsesIBA
01/2021 - 01/2020
2FibrinolysinFDA Link
01/2017 - 01/2015
2Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA
01/2016 - 03/2012
2Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
03/2015 - 12/2011
2LipopolysaccharidesIBA
03/2015 - 08/2014
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2013 - 11/2011
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2004 - 01/2003
1Interleukin-18 (Interleukin 18)IBA
11/2023
1InflammasomesIBA
11/2023
1CuprizoneIBA
11/2023
1Clodronic Acid (Clodronate)IBA
11/2021
1AnticoagulantsIBA
11/2021
1SARS-CoV-2 spike proteinIBA
10/2021
1AutoantibodiesIBA
10/2021
1Apolipoproteins E (ApoE)IBA
01/2021
1Nerve Growth Factors (Neurotrophins)IBA
01/2021
1LDL Receptors (LDL Receptor)IBA
01/2021
1Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
01/2021
1Glutathione (Reduced Glutathione)IBA
01/2020
1acivicin (AT 125)IBA
01/2020
1Amyloid (Amyloid Fibrils)IBA
01/2019
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
10/2018
1GadoliniumIBA
01/2018
1Acetic Acid (Vinegar)FDA LinkGeneric
10/2017
1Glutamic Acid (Glutamate)FDA Link
10/2017
1EnzymesIBA
01/2017
1Complement System Proteins (Complement)IBA
01/2017
1Tranexamic Acid (AMCA)FDA Link
01/2017
1ProgranulinsIBA
01/2017
1estropipate (Ogen)FDA LinkGeneric
01/2016
1EndotoxinsIBA
01/2016
1Chemokine CX3CL1IBA
01/2016
1ChemokinesIBA
09/2015
1Transforming Growth Factors (Transforming Growth Factor)IBA
08/2015
1Sirtuin 1IBA
05/2015
1Cholinergic Agents (Cholinergics)IBA
03/2015
12- (2- furanyl)- 7- (2- (4- (4- (2- methoxyethoxy)phenyl)- 1- piperazinyl)ethyl)- 7H- pyrazolo(4,3- e)(1,2,4)triazolo(1,5- c)pyrimidine- 5- amineIBA
08/2014
1Peptide Hydrolases (Proteases)FDA Link
02/2014

Therapy/Procedure

2Immunotherapy
10/2021 - 11/2018
2Transplantation
11/2017 - 01/2016
2Lasers (Laser)
08/2014 - 12/2012
1Therapeutics
11/2023
1Orthopedic Procedures
03/2015
1Laser Therapy (Surgery, Laser)
08/2014